2012•Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseaseOpen access

Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS

Valérie Desquiret‐Dumas, Naïg Guéguen, Magalie Barth, Arnaud Chevrollier, Saege A. Hancock, Douglas C. Wallace, Patrizia Amati‐Bonneau, Daniel Henrion, Dominique Bonneau, Pascal Reynier, Vincent Procaccio

Open full text 49 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 49 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Heteroplasmy, Mitochondrial myopathy, MELAS syndrome, Mitochondrial DNA, Respiratory chain, Lactic acidosis, Biology, Mitochondrial encephalomyopathy

Related papers

Back to paper searchBrowse research topicsOriginal source
Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS — Research Paper | ScholarLens